Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Comparing electrocoagulation and scalpel techniques in joint replacement surgery

Official title: Electrocoagulation vs. Cold Knife Cutting in Joint Arthroplasty: A Comparative Analysis in Knee and Hip Replacement

Run by Iuliu Hatieganu University of Medicine and Pharmacy · NCT06251869 · Data updated 2026-11-12

This study is testing whether using electrocoagulation instead of a scalpel during hip and knee replacement surgeries can lead to less bleeding, better recovery, and happier patients.

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment700 (estimated)
SponsorIuliu Hatieganu University of Medicine and Pharmacy
Academic / other
Locations1 site (Cluj-Napoca, Cluj)
StatusRecruiting
StartedMarch 15, 2024
Main results expectedFebruary 15, 2027
Study endsFebruary 15, 2027
Registry record updatedMay 1, 2025
Trial IDNCT06251869 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old requiring primary joint replacement due to conditions like symptomatic gonarthrosis or coxarthrosis.

Probably not a fit

Patients with severe medical conditions, active infections, or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of electrocoagulation compared to traditional scalpel techniques in total hip and knee arthroplasty. It aims to measure intraoperative bleeding, surgical visibility, and accuracy during implant placement. Additionally, the study will compare postoperative complications, recovery times, and patient satisfaction between the two methods. Long-term functional outcomes and quality of life will also be assessed to determine the overall impact of the surgical techniques used.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced complications for patients undergoing joint replacement surgery.

How similar studies have gone: Other studies have shown promising results with electrocoagulation techniques in surgical settings, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who have given informed consent to the procedure
* Patients admitted over 18 years of age
* Patients with pathology requiring primary joint replacement (symptomatic gonarthrosis/coxarthrosis, Avascular necrosis (AVN) of the femoral head , femoral neck fractures, etc)

Exclusion Criteria:

* Contraindications for major surgery or anaesthesia
* Patients with active infections that could interfere with outcome assessment
* Patients unable to give informed consent for psychological or cognitive reasons
* Severe medical conditions such as coagulopathies that may significantly influence outcomes
* Patients unable or unwilling to adhere to the required follow-up period
* Patients who died during the study period
* Patients with revision prosthesis operations

Where it's running

  • Clinica Ortopedie-Traumatologie, Secția 2
    Cluj-Napoca, Cluj, Romania
    Recruiting

Study contacts

  • Principal investigator: Benea R Horea, MD — Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Study coordinator: Cicio Dennis
  • Email: ciciodennis@gmail.com
  • Phone: 0752457783

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.